Higher plasma potassium levels associate with increased 30-day mortality in ED patients.
This retrospective cohort study evaluated 248,453 persons attending Emergency Departments in the Capital Region of Denmark between 2017 and 2021. The population included individuals with a plasma potassium level of at least 3.5 mM measured within 4 hours after arrival. The primary outcome was 30-day mortality, with the comparator being a plasma potassium level of 3.5 to 4.4 mM.
The analysis revealed a graded increase in 30-day mortality associated with higher plasma potassium levels. For patients with potassium levels of 4.5 to 4.9 mM, the absolute mortality rate was 6.9%. The adjusted hazard ratio was 1.4 (95% CI: 1.3–1.5). In the group with levels of 5.0 to 5.9 mM, the absolute mortality rate rose to 17.1%, corresponding to an adjusted hazard ratio of 2.10 (95% CI: 1.9–2.3). Patients with potassium levels of 6.0 mM or higher exhibited an absolute mortality rate of 26.9%, with an adjusted hazard ratio of 2.4 (95% CI: 2.0–2.8).
Safety and tolerability data were not reported in the provided text. Key limitations include the risk of residual confounding, missing data, and a lack of access to information regarding in-hospital treatment. The study examines the association between plasma potassium levels and 30-day mortality rather than establishing causality. These findings should be interpreted with caution regarding clinical management decisions.